1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Crump, M.P.
Rajarathnam, K.
Sykes, B.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
273
22471
22479
10.1074/jbc.273.35.22471
9712872
Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.
1998
10.2210/pdb1eot/pdb
pdb_00001eot
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
BOTH SYNTHETIC AND RECOMBINANT SAMPLES WERE PREPARED. RECOMBINANT SAMPLES WERE UNIFORMLY LABELLED WITH N15.
8380.936
EOTAXIN
1
man
polymer
no
no
GPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP
GPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
BOTH SYNTHETIC AND RECOMBINANT SAMPLES WERE PREPARED YES
BL21
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PET15B
database_2
pdbx_database_status
pdbx_nmr_exptl_sample_conditions
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Experimental preparation
Other
1
0
1999-01-13
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_exptl_sample_conditions.pressure_units
_pdbx_nmr_software.name
Y
BNL
1998-06-17
REL
REL
RESONANCE ASSIGNMENTS WERE ACHIEVED USING STANDARD TWO- AND THREE-DIMENSIONAL SEQUENTIAL ASSIGNMENT TECHNIQUES. NMR RESTRAINTS WERE EXTRACTED FROM 50, 75 AND 150 MS NOESY EXPERIMENTS. COUPLING CONSTANTS WERE CALCULATED FROM AN HNHA EXPERIMENT WITH UNIFORMLY LABELLED EOTAXIN.
STRUCTURES WERE SELECTED WITH NO VIOLATIONS > 0.3 A OR DIHEDRAL ANGLES > 0.5 A AND GOOD COVALENT GEOMETRY.
40
1
DQF-COSY
NOESY
TOCSY
RPESY
13C-HSQC
13C-EDITED HMQC-NOESY
15N-NOESY HSQC
15N TOCSY HSQC
20mM SODIUM ACETATE
5.00
1
atm
303
K
STRUCTURES WERE REFINED WITH MULTIPLE ROUNDS OF SIMULATED ANNEALING WITH THE ADDITION OF NEW NOES AND CORRECTION OF UNAMBIGUOUS NOES. PHI ANGLES WERE ONLY ADDED WHEN THEY AGREED WITH THE PURELY NOE DRIVEN CONVERGENCE OF THAT ANGLE IN INITIAL STRUCTURE CALCULATIONS. OTHER REFINEMENT INFORMATION CAN BE FOUND IN THE JRNL CITATION ABOVE.
simulated annealing
90% H2O/10% H2O OR 100% D2O. BUFFER ALSO CONTAINED 1MM DSS AND 1MM SODIUM AZIDE.
BRUNGER
refinement
X-PLOR
3.1
structure solution
VNMR
structure solution
X-PLOR
structure solution
NMRPipe
500
Varian
UNITY 600
600
Varian
INOVA 500
GLY
1
n
1
GLY
1
A
PRO
2
n
2
PRO
2
A
ALA
3
n
3
ALA
3
A
SER
4
n
4
SER
4
A
VAL
5
n
5
VAL
5
A
PRO
6
n
6
PRO
6
A
THR
7
n
7
THR
7
A
THR
8
n
8
THR
8
A
CYS
9
n
9
CYS
9
A
CYS
10
n
10
CYS
10
A
PHE
11
n
11
PHE
11
A
ASN
12
n
12
ASN
12
A
LEU
13
n
13
LEU
13
A
ALA
14
n
14
ALA
14
A
ASN
15
n
15
ASN
15
A
ARG
16
n
16
ARG
16
A
LYS
17
n
17
LYS
17
A
ILE
18
n
18
ILE
18
A
PRO
19
n
19
PRO
19
A
LEU
20
n
20
LEU
20
A
GLN
21
n
21
GLN
21
A
ARG
22
n
22
ARG
22
A
LEU
23
n
23
LEU
23
A
GLU
24
n
24
GLU
24
A
SER
25
n
25
SER
25
A
TYR
26
n
26
TYR
26
A
ARG
27
n
27
ARG
27
A
ARG
28
n
28
ARG
28
A
ILE
29
n
29
ILE
29
A
THR
30
n
30
THR
30
A
SER
31
n
31
SER
31
A
GLY
32
n
32
GLY
32
A
LYS
33
n
33
LYS
33
A
CYS
34
n
34
CYS
34
A
PRO
35
n
35
PRO
35
A
GLN
36
n
36
GLN
36
A
LYS
37
n
37
LYS
37
A
ALA
38
n
38
ALA
38
A
VAL
39
n
39
VAL
39
A
ILE
40
n
40
ILE
40
A
PHE
41
n
41
PHE
41
A
LYS
42
n
42
LYS
42
A
THR
43
n
43
THR
43
A
LYS
44
n
44
LYS
44
A
LEU
45
n
45
LEU
45
A
ALA
46
n
46
ALA
46
A
LYS
47
n
47
LYS
47
A
ASP
48
n
48
ASP
48
A
ILE
49
n
49
ILE
49
A
CYS
50
n
50
CYS
50
A
ALA
51
n
51
ALA
51
A
ASP
52
n
52
ASP
52
A
PRO
53
n
53
PRO
53
A
LYS
54
n
54
LYS
54
A
LYS
55
n
55
LYS
55
A
LYS
56
n
56
LYS
56
A
TRP
57
n
57
TRP
57
A
VAL
58
n
58
VAL
58
A
GLN
59
n
59
GLN
59
A
ASP
60
n
60
ASP
60
A
SER
61
n
61
SER
61
A
MET
62
n
62
MET
62
A
LYS
63
n
63
LYS
63
A
TYR
64
n
64
TYR
64
A
LEU
65
n
65
LEU
65
A
ASP
66
n
66
ASP
66
A
GLN
67
n
67
GLN
67
A
LYS
68
n
68
LYS
68
A
SER
69
n
69
SER
69
A
PRO
70
n
70
PRO
70
A
THR
71
n
71
THR
71
A
PRO
72
n
72
PRO
72
A
LYS
73
n
73
LYS
73
A
PRO
74
n
74
PRO
74
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ILE
49
A
O
ILE
49
A
N
PHE
41
A
N
PHE
41
A
O
ALA
38
A
O
ALA
38
A
N
ILE
29
A
N
ILE
29
1
A
ALA
3
-69.32
84.05
1
A
SER
4
62.99
-80.04
1
A
THR
8
-139.11
-66.51
1
A
SER
25
-170.08
-175.29
1
A
THR
30
-164.18
31.73
1
A
LYS
44
-97.68
30.03
1
A
SER
69
-57.07
174.95
1
A
LYS
73
51.53
164.76
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
SOLUTION NMR STRUCTURE OF EOTAXIN, MINIMIZED AVERAGE STRUCTURE
1
Y
N
A
TRP
57
A
TRP
57
HELX_P
A
LYS
68
A
LYS
68
1
1
12
disulf
2.020
A
CYS
9
A
SG
CYS
9
1_555
A
CYS
34
A
SG
CYS
34
1_555
disulf
2.021
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
50
A
SG
CYS
50
1_555
CYTOKINE
CYTOKINE, CHEMOKINE, PROTEIN SYNTHESIS, EOTAXIN, SOLUTION STRUCTURE, CCR3, EOSINOPHIL
CCL11_HUMAN
UNP
1
1
P51671
MKVSAALLWLLLIAAAFSPQGLAGPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKW
VQDSMKYLDQKSPTPKP
24
97
1EOT
1
74
P51671
A
1
1
74
3
anti-parallel
anti-parallel
A
ASP
48
A
ASP
48
A
ALA
51
A
ALA
51
A
ALA
38
A
ALA
38
A
THR
43
A
THR
43
A
SER
25
A
SER
25
A
ILE
29
A
ILE
29
1
P 1